Compugen Statistics
Total Valuation
Compugen has a market cap or net worth of $190.12 million. The enterprise value is $58.10 million.
| Market Cap | 190.12M |
| Enterprise Value | 58.10M |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Compugen has 94.58 million shares outstanding. The number of shares has increased by 4.60% in one year.
| Current Share Class | 94.58M |
| Shares Outstanding | 94.58M |
| Shares Change (YoY) | +4.60% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 15.32% |
| Float | 92.44M |
Valuation Ratios
The trailing PE ratio is 5.42.
| PE Ratio | 5.42 |
| Forward PE | n/a |
| PS Ratio | 2.62 |
| Forward PS | 23.59 |
| PB Ratio | 1.99 |
| P/TBV Ratio | 1.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.67 |
| EV / Sales | 0.80 |
| EV / EBITDA | 1.86 |
| EV / EBIT | 1.89 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.23, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.23 |
| Quick Ratio | 6.23 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 45.72% and return on invested capital (ROIC) is 24.27%.
| Return on Equity (ROE) | 45.72% |
| Return on Assets (ROA) | 14.69% |
| Return on Invested Capital (ROIC) | 24.27% |
| Return on Capital Employed (ROCE) | 24.80% |
| Weighted Average Cost of Capital (WACC) | 19.03% |
| Revenue Per Employee | $968,747 |
| Profits Per Employee | $464,733 |
| Employee Count | 75 |
| Asset Turnover | 0.56 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Compugen has paid $28,000 in taxes.
| Income Tax | 28,000 |
| Effective Tax Rate | 0.08% |
Stock Price Statistics
The stock price has increased by +21.82% in the last 52 weeks. The beta is 2.74, so Compugen's price volatility has been higher than the market average.
| Beta (5Y) | 2.74 |
| 52-Week Price Change | +21.82% |
| 50-Day Moving Average | 2.59 |
| 200-Day Moving Average | 1.97 |
| Relative Strength Index (RSI) | 33.95 |
| Average Volume (20 Days) | 478,086 |
Short Selling Information
The latest short interest is 2.45 million, so 2.59% of the outstanding shares have been sold short.
| Short Interest | 2.45M |
| Short Previous Month | 1.69M |
| Short % of Shares Out | 2.59% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.55 |
Income Statement
In the last 12 months, Compugen had revenue of $72.66 million and earned $34.86 million in profits. Earnings per share was $0.37.
| Revenue | 72.66M |
| Gross Profit | 63.98M |
| Operating Income | 30.70M |
| Pretax Income | 34.88M |
| Net Income | 34.86M |
| EBITDA | 31.18M |
| EBIT | 30.70M |
| Earnings Per Share (EPS) | $0.37 |
Balance Sheet
The company has $134.95 million in cash and $2.93 million in debt, with a net cash position of $132.01 million or $1.40 per share.
| Cash & Cash Equivalents | 134.95M |
| Total Debt | 2.93M |
| Net Cash | 132.01M |
| Net Cash Per Share | $1.40 |
| Equity (Book Value) | 95.35M |
| Book Value Per Share | 1.01 |
| Working Capital | 115.25M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 472,250 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 88.06%, with operating and profit margins of 42.26% and 47.97%.
| Gross Margin | 88.06% |
| Operating Margin | 42.26% |
| Pretax Margin | 48.01% |
| Profit Margin | 47.97% |
| EBITDA Margin | 42.91% |
| EBIT Margin | 42.26% |
| FCF Margin | n/a |
Dividends & Yields
Compugen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.60% |
| Shareholder Yield | -4.60% |
| Earnings Yield | 18.33% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Compugen is $4.60, which is 128.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.60 |
| Price Target Difference | 128.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | -30.24% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |